Skip to main content
    T

    Tandem Diabetes Care Inc (TNDM)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $18.48
    -1.59 (-7.92%)

    Market Cap: $1.40B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Tandem Diabetes Care Inc (TNDM) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Tandem Diabetes Care (TNDM) is expected to report earnings on Feb 17, 2027. In the quarter ended Sep 30, 2026, Tandem Diabetes Care reported EPS of -$0.10, above the -$0.27 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    56%(22/39)
    Avg Surprise
    -8.19%
    Streak
    5 Q

    Upcoming Estimates

    Reports Feb 17, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.10
    Range-$0.01 - $0.22
    26 analysts
    Revenue Consensus
    $297.39M
    Range$273.91M - $315.11M
    25 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.15
    Range-$0.25 - $0.00
    16 analysts
    EPS Revisions
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.11-32.9%
    60d ago-$0.11-32.9%
    30d ago-$0.11-30.5%
    7d ago-$0.11-30.5%
    Current-$0.15
    Revenue Consensus
    $263.84M
    Range$252.00M - $277.30M
    18 analysts

    Next Report

    TNDM has an expected report date of Feb 17, 2027.

    TNDM Earnings Call

    The latest TNDM earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 39 quarters below that had an estimate, TNDM beat 22, missed 16 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $283.69M, up 13.8% from $249.25M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.10-$0.27-$0.36 - -$0.16+62.96%BeatN/A203 up, 12 downNov 5, 2026$283.69M
    Jun 30, 2026-$0.31-$0.34-$0.41 - -$0.23+8.82%BeatN/A181 up, 3 downAug 6, 2026$254.56M
    Mar 31, 2026-$0.30-$0.44-$0.54 - -$0.35+31.82%BeatN/A185 up, 10 downMay 7, 2026$247.22M
    Dec 31, 2025-$0.01-$0.09-$0.40 - $0.03+88.89%BeatN/A212 up, 1 downFeb 19, 2026$290.38M
    Sep 30, 2025-$0.31-$0.34-$0.54 - -$0.07+8.82%BeatN/A203 up, 15 downNov 6, 2025$249.25M
    Jun 30, 2025-$0.48-$0.40-$0.57 - -$0.26-20.00%MissN/A201 up, 0 downAug 6, 2025$240.68M
    Mar 31, 2025-$0.67-$0.61-$0.67 - -$0.49-9.84%MissN/A200 up, 1 downApr 30, 2025$234.42M
    Dec 31, 2024-$0.44-$0.24-$0.37 - -$0.05-84.81%MissN/A172 up, 9 downFeb 26, 2025$282.65M
    Sep 30, 2024-$0.36-$0.41-$0.50 - -$0.27+12.20%BeatN/A191 up, 0 downNov 6, 2024$243.97M
    Jun 30, 2024-$0.48-$0.53-$0.61 - -$0.35+9.43%BeatN/A110 up, 0 downAug 1, 2024$221.91M
    Mar 31, 2024-$0.64-$0.76-$0.85 - -$0.58+15.79%BeatN/A120 up, 0 downMay 2, 2024$191.67M
    Dec 31, 2023-$0.27-$0.25-$0.40 - -$0.10-8.00%MissN/A130 up, 0 downFeb 21, 2024$196.80M
    Sep 30, 2023-$0.38-$0.36-$0.59 - $0.02-5.56%MissN/A140 up, 0 downNov 1, 2023$185.62M
    Jun 30, 2023-$0.30-$0.49-$0.63 - -$0.43+38.78%BeatN/A80 up, 0 downAug 3, 2023$195.92M
    Mar 31, 2023-$0.63-$0.53-$0.69 - -$0.26-18.87%MissN/A120 up, 0 downMay 3, 2023$169.38M
    Dec 31, 2022-$0.25-$0.06-$0.22 - $0.07-316.67%Miss-256.3%130 up, 0 downFeb 22, 2023$220.50M
    Sep 30, 2022-$0.27-$0.05-$0.18 - $0.06-440.00%Miss-400.0%130 up, 0 downNov 2, 2022$204.55M
    Jun 30, 2022-$0.23$0.02-$0.04 - $0.17N/AN/A-483.3%110 up, 1 downAug 3, 2022$200.26M
    Mar 31, 2022-$0.23-$0.07-$0.23 - $0.17-228.57%MissN/A113 up, 0 downMay 4, 2022$175.91M
    Dec 31, 2021$0.16$0.21$0.10 - $0.33-23.81%Miss-27.3%120 up, 0 downFeb 22, 2022$210.00M
    Sep 30, 2021$0.09$0.06-$0.02 - $0.18+50.00%BeatN/A15N/ANov 3, 2021$179.63M
    Jun 30, 2021$0.06-$0.08-$0.28 - $0.03+175.00%BeatN/A15N/AAug 4, 2021$172.14M
    Mar 31, 2021-$0.08-$0.15-$0.28 - -$0.04+46.67%BeatN/A14N/AMay 5, 2021$141.04M
    Dec 31, 2020$0.22$0.12$0.03 - $0.23+83.33%Beat+450.0%14N/AFeb 24, 2021$168.06M
    Sep 30, 2020-$0.15-$0.12-$0.28 - $0.05-25.00%MissN/A15N/ANov 5, 2020$123.60M
    Jun 30, 2020-$0.45-$0.25-$0.35 - -$0.09-80.00%MissN/A14N/AJul 30, 2020$109.24M
    Mar 31, 2020-$0.25-$0.18-$0.29 - -$0.08-38.89%MissN/A14N/AApr 30, 2020$97.93M
    Dec 31, 2019$0.04-$0.05-$0.21 - $0.10+180.00%Beat+100.0%13N/AFeb 24, 2020$108.40M
    Sep 30, 2019-$0.09-$0.22-$0.38 - -$0.13+59.09%BeatN/A12N/ANov 4, 2019$94.66M
    Jun 30, 2019-$0.03-$0.29-$0.42 - -$0.15+89.66%BeatN/A12N/AAug 1, 2019$93.25M
    Mar 31, 2019-$0.40-$0.29-$0.41 - -$0.14-37.93%MissN/A12N/AApr 30, 2019$66.00M
    Dec 31, 2018$0.02-$0.20-$0.24 - -$0.14+110.00%BeatN/A11N/AFeb 26, 2019$76.20M
    Sep 30, 2018-$0.30-$0.31-$0.46 - -$0.21+3.23%BeatN/A10N/ANov 1, 2018$46.26M
    Jun 30, 2018-$0.33-$0.33-$0.39 - -$0.310.00%In lineN/A6N/AJul 30, 2018$34.13M
    Mar 31, 2018-$1.03-$0.62-$0.74 - -$0.45-66.13%MissN/A6N/AApr 26, 2018$27.28M
    Dec 31, 2017-$1.22-$1.30-$1.87 - -$1.02+6.15%BeatN/A5N/AMar 1, 2018$40.29M
    Sep 30, 2017-$3.59-$3.74N/A+4.01%BeatN/AN/AN/AOct 26, 2017$27.00M
    Jun 30, 2017-$4.40-$4.79N/A+8.14%BeatN/AN/AN/AJul 27, 2017$21.33M
    Mar 31, 2017-$7.50-$6.11N/A-22.75%MissN/AN/AN/AApr 27, 2017$18.98M
    Dec 31, 2016-$5.55-$6.49N/A+14.48%BeatN/AN/AN/AMar 8, 2017$28.91M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.47, after -$1.92 the year before. It was -$28.05 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.47N/A
    Dec 31, 2024-$1.92N/A
    Dec 31, 2023-$1.58N/A
    Dec 31, 2022-$0.98-526.1%
    Dec 31, 2021$0.23N/A
    Dec 31, 2020-$0.63N/A
    Dec 31, 2019-$0.48N/A
    Dec 31, 2018-$1.64N/A
    Dec 31, 2017-$16.71N/A
    Dec 31, 2016-$28.05N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,200 words across 18 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20267,21518
    2026Q2Jun 30, 20266,70917
    2026Q1Mar 31, 20268,19724
    2025Q4Dec 31, 20258,96822
    2025Q3Sep 30, 20258,29317
    2025Q2Jun 30, 20258,50319
    2025Q1Mar 31, 20259,02423
    2024Q4Dec 31, 202411,24223

    2026Q3 Earnings Call

    Opening remarks

    Susan Morrison Executive Vice President and Chief Administrative Officer Hello, and welcome to Tandem's 2026 Third Quarter Earnings Call. Today's discussion will include forward-looking statements, including statements about our CEO transition and its timing, our leadership, strategy, product pipeline, development timelines, financial performance, including profitability and operating plans. These statements speak only as of today's date. They reflect our current expectations about future events and are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in our forward-looking statements, which are described in our press release issued earlier today and under the Risk Factors portion of our most recent annual report on Form 10-K and quarterly report on Form 10-Q, as well as the Form 8-K we issued today. Today's discussion will also include references to both GAAP and non-GAAP financial measures. Please refer to our earnings release issued today and available on the Investor Center portion of our website for a reconciliation of non-GAAP measures to their most directly comparable GAAP financial measure and other information regarding our use of non-GAAP financial measures. In addition, we also issued a press release this afternoon on the planned evolution of Tandem's CEO leadership. To speak to this announcement, the Chair of Tandem's Board of Directors, Beckie Robertson, will join us in opening today's call. We'll then move to our third quarter earnings results and company update from John Sheridan, President and CEO, and Leigh Vosseller, Executive Vice President and Chief Financial Officer. After their prepared remarks, we'll open the call for questions with John and Leigh. Thank you in advance for limiting yourself to one question before rejoining the queue. I'll now turn the call over to Beckie.

    Rebecca Robertson Chair of the Board of Directors Thanks, Susan, and good afternoon, everyone. Today's succession announcement marks an important milestone for Tandem Diabetes Care. As part of a planned leadership transition, we celebrate John Sheridan's accomplished tenure as he prepares to retire at the end of 2026, and we are thrilled to welcome Jeannette Bankes as Tandem's next President and CEO. On behalf of the Board, I want to thank John for more than a decade of service to Tandem, including eight years as CEO. Under John's leadership, Tandem has grown into a global innovator in diabetes care. He launched Control-IQ, our first hybrid closed-loop technology, advanced our digital health strategy, and expanded our portfolio with the introduction of Mobi. In addition, he established the foundation for Tandem to operate at scale internationally and set in motion business model changes that broaden customer access. Just as important, he cultivated a mission-driven culture that will continue to define this company. With this foundation in place, Jeannette is the right leader to guide Tandem through its next phase of growth.

    Frequently Asked Questions About TNDM

    When is Tandem Diabetes Care's next earnings date?

    Tandem Diabetes Care's next earnings report is expected for Feb 17, 2027.

    Did TNDM beat earnings estimates last quarter?

    Yes. Tandem Diabetes Care reported EPS of -$0.10 for the quarter ended Sep 30, 2026, above the -$0.27 estimate, a 62.96% surprise.

    What EPS do analysts expect from TNDM next quarter?

    The consensus EPS estimate for Tandem Diabetes Care for the quarter ending Dec 31, 2026 is $0.10 from 26 analysts, with estimates from -$0.01 to $0.22.

    How often does TNDM beat earnings estimates?

    Tandem Diabetes Care beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +10.83%.